Pharmaceutical

AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine  

The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024.

Mar 9, 2024 - 18:00
AD/PD 2024: Vaxxinity reveals Phase I success with Parkinson’s vaccine  
The company revealed the data at the Alzheimer’s Disease and Parkinson’s Disease (AD/PD) Conference 2024.
Read the original article

Tags:

Previous Article

BeiGene secures accelerated FDA approval for follicular lymphoma treatment

Next Article

Amylyx considers scrapping ALS drug following Phase III flop

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Listen: Ezekiel Emanuel explains why cancer patients shouldn’t pay out-of-pocket costs

Opinion: Listen: Ezekiel Emanuel explains why cancer pa...

May 31, 2023

STAT+: Sly CAR-T strategy evades ‘fratricide’ problem to aim at all blood cancers

STAT+: Sly CAR-T strategy evades ‘fratricide’ problem t...

Aug 31, 2023

Can reforms restore faith in India’s pharma industry after cough syrup scandals?

Can reforms restore faith in India’s pharma industry af...

Sep 29, 2023